Skip to main content

1 Result(s)

within Biomedicine Remove this filter Cancer Research Remove this filter Reproductive Medicine Remove this filter Matthew K H Hong Remove this filter

and

  1. No Access

    Article

    MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer

    Recent publications have shown patients with defects in the DNA mismatch repair (MMR) pathway driven by either MSH2 or MSH6 loss experience a significant increase in the incidence of prostate cancer. Moreover,...

    Patrick McCoy, Stefano Mangiola, Geoff Macintyre… in Prostate Cancer and Prostatic Diseases (2021)